Tema ETFs’s Viking Therapeutics VKTX Stock Holding History

Tema ETFs’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$273K	Sell	8,370 -56	-0.7%	-$1.94K	0.01%	508
2026 Q2	$329K	Sell	8,426 -5,441	-39%	-$176K	0.01%	474
2026 Q1	$451K	Sell	13,867 -180	-1%	-$5.78K	0.03%	388
2025 Q4	$494K	Buy	+14,047	New	+$498K	0.04%	360
2025 Q3	–	Sell	-19,755	Closed	-$524K	–	528
2025 Q2	$524K	Buy	19,755 +524	+3%	+$13.8K	0.14%	136
2025 Q1	$464K	Sell	19,231 -984	-5%	-$31.1K	0.14%	115
2024 Q4	$813K	Buy	+20,215	New	+$1.15M	0.34%	72

Other funds holding VKTX

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Quantum Private Wealth Tampa, Florida $391M AUM 50.76% 1-Year Est. Return

Lewis Asset Management Lafayette, California $294M AUM 25.62% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Royal Fund Management Lady Lake, Florida $1.26B AUM 23.83% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

PVG Asset Management Golden, Colorado $147M AUM 52.72% 1-Year Est. Return

Tema ETFs's VKTX Position: Q3 2026 in Review

Tema ETFs reduced its Viking Therapeutics (VKTX) stake by 0.66% in Q3 2026, selling an estimated $1.94K and leaving 8,370 shares worth $273K. The position accounts for 0.01% of the portfolio, ranked #508.

Tema ETFs first reported a position in VKTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $813K in Q4 2024. 68 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.

Tema ETFs held 8,370 shares of Viking Therapeutics worth $273K as of Q3 2026.
Tema ETFs sold 56 Viking Therapeutics shares in Q3 2026, an estimated $1.94K.
Viking Therapeutics made up 0.01% of Tema ETFs's portfolio in Q3 2026, its #508 holding.
Tema ETFs first reported a position in Viking Therapeutics in Q4 2024 and has held it in 7 quarters since.
Tema ETFs's Viking Therapeutics position peaked at $813K in Q4 2024.
68 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.